Self-Management in Young Adults With Type 1 Diabetes
Completed · Not applicable
Conditions studied: Type 1 Diabetes
In brief
Type 1 Diabetes (T1D) affects 1.6 million Americans, and only 14% of young adults age 18-25 years achieve glycemic targets (glycosylated hemoglobin A1C \<7.0%). Achieving glycemic targets is associated with reduced risk for both micro-and macrovascular complications, better neurocognitive function, and better diabetes quality of life. In lab studies, sleep deprivation led to impaired glucose tolerance and insulin sensitivity in adults without chronic condition and in one study of adults with T1D. Extending sleep in natural environments contributes to improved insulin sensitivity and glucose levels, neurocognition, and psychological symptoms in young adults without chronic conditions. Modifiable dimensions of sleep health (appropriate sleep duration, stability, and timing) are associated with better glycemic control in adults with T1D. Therefore, improving sleep duration, stability, and timing may be potential therapeutic targets to improve glucoregulation and clinical outcomes (diabetes self-management, neurocognitive function, and symptoms) in this high-risk population. The overall objective is to test and compare the effects of a cognitive-behavioral sleep self-management intervention (sleep extension and consistency in sleep timing) compared to an attention control condition (habitual sleep duration + diabetes self-management education) on improving sleep duration, stability, and timing, and glycemia (glycemic control and glucose variability) in short-sleeping young adults with T1D in a pilot randomized controlled trial.
Key facts
- Study ID
- NCT04975230
- Run by
- Case Western Reserve University
- People needed
- 39
- Starts
- 2022-04-29
- Expected to finish
- 2023-11-01
- Last updated by the study team
- 2026-01-12
Who can join
Age: 18 and older, up to 26. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 1) Age range: from 18 to 26 years
- 2) Diagnosed with T1D for at least 6 months
- 3) No other major health problems (e.g., chronic medical condition or major psychiatric illness
- 4) Not currently participating in any intervention studies
- 5) Read/speak English
- 6) Have a most recent A1C or eA1C value ≥ 7%.
You may not qualify if…
- 1) Previous OSA diagnosis/high-risk sleep apnea
- 2) Current pregnancy
- 3) Night shift workers
- 4) Habitually sleep > 7 hours on work or school days.
Where it is running
- University Hospitals of Cleveland Medical Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.